The Direct Index
Report · scanned 2026-10-19

What an AI agent reads on Cell-Innovations

An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from cell-innovations.com.au, taken from the copy the scanner kept.

3,597

characters of text without JavaScript

none

structured data for the business

0

of 3 AI crawlers turned away at the edge

Text

The words an agent gets

Title: SVF Cell Therapy | Australia | Cell Innovations - Cell-Innovations · language en-US. First 1,800 of 3,597 characters:

SVF Cell Therapy | Australia | Cell Innovations - Cell-Innovations FOR CELL THERAPY IN YOUR CLINIC CALL 1300 738 025 Home Information for Doctors Overview Why Adipose? How it Works Our Package Cell Differentiation Studies Regulations SVF Outcomes Osteoarthritis Knee Outcomes Osteoarthritis Hip Outcomes Migraine Outcomes References Clinical Trials About Us Corporate Profile Intellectual Property Contact Us Login Provide an innovative and promising SVF therapy to your valued patients… Join a research group on the forefront of regenerative medicine using SVF cells… Our packages can provide you the patented technology to perform SVF therapy… FOR DOCTORS Discover our comprehensive package with all of the patented technology you require... Find Out More HOSPITALS Hospitals and medical clinics nationally and internationally have chosen our Cell-Innovations package... Find Out More About Cell-Innovations Cell-Innovations patented technology Cell-Innovations is an Australian-owned company involved in developing and commercialising cutting-edge regenerative medical technologies. Cell-Innovations is engaged in clinical and basic science studies to test the application of autologous Stromal Vascular Fraction (SVF) for various clinical indications. Cell-Innovations has developed a portfolio of licensed technologies that deliver efficient and reliable separation of Stromal Vascular Fraction (SVF) cells from adipose tissue (a patient’s own fat) in a clinical setting. The autologous SVF is separated and administered to the patient in a single surgical sitting. The Cell-Innovations proprietary technology has been used in clinical practice since 2012, and looks set to help shape the future of therapeutic approaches to musculoskeletal conditions such as osteoarthritis. Cell-Innovations is
Facts

What it can say about the business

A business type in JSON-LDno
Nameno
Telephoneno
Addressno
Opening hoursno
Menu or price listnothing
Cuisine in structured datano
JSON-LD blocks1 (BreadcrumbList, EntryPoint, ListItem, ReadAction, SearchAction, WebPage)
Actions

The links it would act on

LinkRoleWhere it goes
www.cell-innovations.com.au/stem-cell-treatments/bookingthe business's own site

Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.